Weir D C, Robertson A S, Gove R I, Burge P S
Department of Thoracic Medicine, East Birmingham Hospital.
Thorax. 1990 Feb;45(2):118-21. doi: 10.1136/thx.45.2.118.
One hundred and twenty one patients considered on clinical grounds to have non-asthmatic chronic airflow obstruction completed a double blind, crossover trial comparing oral prednisolone 40 mg per day with inhaled beclomethasone dipropionate 500 micrograms thrice daily, each given for 14 days, with a 14 day washout period between treatments. The time course of response was analysed for the 57 occasions where there was a significant increase in mean daily peak expiratory flow (PEF) over the treatment period. Mean daily PEF was still rising at day 14 on 12 occasions. After withdrawal of treatment mean daily PEF remained above pretreatments levels for more than two weeks in half the responses analysed. The peak response occurred earlier with inhaled beclomethasone (median 9.5 (range 3-14) days) than with oral prednisolone (median 12 (range 1-14) days), though both treatments produced a response that was sustained for a similar period. The results suggest that a trial of treatment with corticosteroids in this group of patients should last more than 14 days, and that in a study with a crossover design the washout period should be longer than two weeks.
121名经临床诊断为非哮喘性慢性气流阻塞的患者完成了一项双盲交叉试验,该试验比较了每日口服40毫克泼尼松龙与每日三次吸入500微克二丙酸倍氯米松的疗效,每种治疗均持续14天,治疗期间有14天的洗脱期。对治疗期间平均每日呼气峰值流速(PEF)显著增加的57例情况进行了反应时间过程分析。12例在第14天时平均每日PEF仍在上升。在分析的一半反应中,停药后平均每日PEF在两周多的时间里仍高于治疗前水平。吸入二丙酸倍氯米松的峰值反应(中位数9.5(范围3 - 14)天)比口服泼尼松龙(中位数12(范围1 - 14)天)出现得更早,尽管两种治疗产生的反应持续时间相似。结果表明,对该组患者进行皮质类固醇治疗试验应持续超过14天,并且在交叉设计的研究中,洗脱期应长于两周。